Arthur Tzianabos, Ph.D., June Lee, MD, FACCP, and Joseph Loscalzo, MD, PhD Join 5AM Ventures

News
2022
2021
Archive

August 22, 2022

CinCor Pharma Announces Presentation of Phase 1 Clinical Data for Baxdrostat at the Upcoming European Society of Cardiology 2022 Congress
August 22, 2022

Arvinas Announces Changes to its Board of Directors
August 18, 2022

Arvinas Appoints Lisa Sinclair as Senior Vice President, Corporate Operations
August 16, 2022

CinCor Pharma Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
August 11, 2022

Homology Medicines Announces Optimized, In Vivo Gene Therapy Candidate for the Treatment of Metachromatic Leukodystrophy
August 11, 2022

Nouscom Announces Leading Publication Revealing an Immune Mechanism of Action Driving Anti-Tumor Activity of Adenovirus Vectored Vaccines and Anti-PD1 Immunotherapy
August 10, 2022

Pear Therapeutics Announces Publication of New Analysis of Real-World Data Showing Reduction in Insomnia Severity, Healthcare Resource Utilization and Associated Costs in Adults Using Somryst®
August 9, 2022

CCRM Fertility and TMRW Life Sciences to Expand Partnership Modernizing IVF Specimen Management Across All Locations
August 8, 2022

Pear Therapeutics and SelectHealth Announce Coverage to Provide Access to FDA-Authorized Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder
August 8, 2022

CinCor Pharma Announces Positive Topline Data for Phase 2 BrigHtn Trial Evaluating Baxdrostat, its Selective Aldosterone Synthase Inhibitor, in Treatment-Resistant Hypertension

© 2022 5AM Venture Management LLC